Published
???? New hope for high Lp(a)!
???? Lepodisiran, a long-acting siRNA, slashed Lp(a) by 94% with just 2 shots/year.
???? RNA precision meets cardiac prevention.
???? Silent killer, silenced.
#CardioTwitter #RNAtherapy #LipoproteinA
???? Lepodisiran, a long-acting siRNA, slashed Lp(a) by 94% with just 2 shots/year.
???? RNA precision meets cardiac prevention.
???? Silent killer, silenced.
#CardioTwitter #RNAtherapy #LipoproteinA
- Category
- Cardiology
Be the first to comment
Up Next
-
09:30
Do this to Lower Cancer Risk - it's Free!
-
04:54
Molecular Biomarkers and Risk Stratification in High-Risk Non-Muscle Invasive Bladder Cancer
-
04:08
45 yaş üstü o kanserde risk artıyor!
-
12:36
How Lupus Silently Affects Your Heart - Are You at Risk?
-
07:16
Do This 1 Thing With Your Coffee or Risk Heart Disease
-
07:26
Dr. Steven Nissen and Dr. Mohammad Hossain on ALPACA Phase 2 Trial of Lepodisiran
-
11:36
The Hidden Heart Risk Markers You Need to Know.
-
12:10
Understanding Deterioration: Key Causes and Risk Factors
-
07:07
Top Risk Factors for AFib: What You Need to Know
-
05:00
Colorectal Cancer: Screening and Risk Factors
-
09:07
Cardiology for Beginners: Basics of Heart Sounds and Murmurs (with examples)
-
13:45
How to Become a Cardiologist | Cardiac Electrophysiologist
-
04:14
V 00592 Cardiology Fellowship Video Dr Vranian V5
-
05:17
Cardiology Fellowship at SIU Medicine
-
04:15
Cardiology Fellowship Program at Danbury Hospital
-
05:49
Practice Question: Cardiology #1, USMLE Step 1, COMLEX Level 1
-
04:07
Dr. Muhammed Raza on advice for Fellows interested in Interventional Cardiology
-
07:36
Congenital Heart Disease – Cardiology | Lecturio
-
05:18
Cardiology Fellowship at IU School of Medicine
-
04:36
What are different types of Cardiology Tests | SPS Hospitals
